Related Experiment Video
Updated: Jun 6, 2026

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
A potential Adjunctive Role of 7T MRI and Amino-Acid PET in Localizing MRI-Occult Functional Pituitary Microadenomas:
Neetu Soni1, Manish Ora2, Yu Cai2
1From the Department of Radiology (N.S., Y.C., V.G., P.V., J.V.M., S.J.S.S., E.H.M.), Nuclear Medicine (M.J., C.R.G., E.E.P.), DIVISION CHAIR-ENDO/METAB Department of Internal Medicine (S.L.S.), Mayo Clinic, Jacksonville, FL, USA; Department of Nuclear Medicine (M.O.), Sanjay Gandhi Post Graduate Institute of Medical Science, Lucknow, India; Department of Radiology (Y.C.), Zhongda Hospital, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology, School of Medicine, Southeast University, 87 Dingjiaqiao Rd, Gulou District, Nanjing 210009, China; Department of Radiology (I.T.M., B.J.B., G.B.), Mayo Clinic, Rochester, USA; Professor at The University of Texas MD Anderson Cancer Center (A.A.) and Department of Radiology & Nuclear Medicine (S.E.M.V.V.Z.), Erasmus MC - University Medical Centre Rotterdam, Rotterdam, the Netherlands; Brain Tumour Centre, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Medical Delta, Delft, the Netherlands. Soni.Neetu@mayo.edu.
Background:
Functional pituitary adenomas (FPAs), especially those "MRI-occult" on 1.5T/3T and smaller than 10 mm, present diagnostic and therapeutic challenges, leading to repeated investigations, invasive procedures, and suboptimal outcomes. This review examines the potential clinical use and limitations of 7T MRI and amino-acid (AA)-PET with tracers like L-[methyl-11C]methionine (MET) or O-(2-[18F]fluoroethyl)-L-tyrosine (FET) for detecting MRI-occult FPAs.
Materials And Methods:
A systematic search of Medline, Embase, and Web of Science was performed up to August 2025, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies evaluating 7T MRI and AA-PET for MRI-occult PAs were included and independently reviewed by three authors. Eighteen studies met inclusion criteria: 4 evaluated the 7T MRI, 8 MET-PET, three FET-PET, and three hybrid/multi-tracer approaches.
Results:
7T MRI offers superior spatial resolution, increased signal-to-noise ratio, and improved tissue contrast. AA-PET provides high tumor-to-background contrast, facilitating MRI-occult PAs localization.
Conclusions:
Despite these advances, small cohort sizes, heterogeneous protocols, high costs, and limited accessibility limit the current evidence base. Ultra-high-field 7T MRI and AA-PET represent emerging complementary imaging techniques for MRI-occult FPAs. Current evidence is preliminary, underscoring the need to standardize protocols, conduct prospective multicenter studies, and assess cost-effectiveness before widespread clinical adoption.
Insights
Ultra-high-field 7T MRI and amino-acid PET show promise for detecting small, MRI-occult functional pituitary adenomas. Further research is needed to establish standardized protocols and assess cost-effectiveness for clinical use.
Area of Science:
- Medical Imaging
- Nuclear Medicine
- Endocrinology
Background:
- Functional pituitary adenomas (FPAs) smaller than 10 mm are often "MRI-occult" on standard MRI, posing diagnostic challenges.
- This leads to repeated investigations and suboptimal patient outcomes.
- Detecting these small adenomas is crucial for timely diagnosis and treatment.
Purpose of the Study:
- To review the clinical utility and limitations of 7T MRI and amino-acid Positron Emission Tomography (AA-PET) for detecting "MRI-occult" FPAs.
- To evaluate advanced imaging techniques for improved FPA localization.
- To assess the current evidence for these emerging technologies.
Main Methods:
- A systematic literature search was conducted across Medline, Embase, and Web of Science up to August 2025.
- Studies evaluating 7T MRI and AA-PET (using tracers like L-[methyl-11C]methionine or O-(2-[18F]fluoroethyl)-L-tyrosine) for MRI-occult PAs were included.
- Eighteen studies met the inclusion criteria, covering 7T MRI, MET-PET, FET-PET, and hybrid approaches.
Main Results:
- 7T MRI demonstrates superior spatial resolution, signal-to-noise ratio, and tissue contrast compared to lower field strengths.
- AA-PET offers high tumor-to-background contrast, aiding in the localization of "MRI-occult" FPAs.
- Both techniques show potential for improved detection rates.
Conclusions:
- Ultra-high-field 7T MRI and AA-PET are promising complementary imaging modalities for "MRI-occult" FPAs.
- Current evidence is limited by small cohort sizes, heterogeneous protocols, cost, and accessibility.
- Prospective multicenter studies and cost-effectiveness analyses are needed for clinical adoption.
Related Concept Videos
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Magnetic Resonance Imaging
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET